Citation Impact
Citing Papers
Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8+ T cells and dendritic cells
2013
Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction
2020 Standout
CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
2015
Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee
2020 Standout
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
2019 Standout
Nucleoside-catabolizing Enzymes in Mycoplasma-infected Tumor Cell Cultures Compromise the Cytostatic Activity of the Anticancer Drug Gemcitabine
2014
Hemophagocytic lymphohistiocytosis in an adult kidney transplant recipient successfully treated by plasmapheresis
2017
Mechanisms and insights into drug resistance in cancer
2013
Acute liver failure caused by hemophagocytic lymphohistiocytosis in adults
2016
Recycling endosomes
2015
Platelet-derived alpha-granules are associated with inflammation in patients with NK/T-cell lymphoma-associated hemophagocytic syndrome
2019
A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
Gut microbiota modulation of chemotherapy efficacy and toxicity
2017 Standout
Mechanism-Based Precision Therapy for the Treatment of Primary Immunodeficiency and Primary Immunodysregulatory Diseases
2019
Whole-Exome Sequencing Reveals Mutations in Genes Linked to Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome in Fatal Cases of H1N1 Influenza
2015
Adult haemophagocytic syndrome
2013
A Red Carpet for Iron Metabolism
2017
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
2020 Standout
Differential Regulation of Lipoprotein and Hepatitis C Virus Secretion by Rab1b
2017 StandoutNobel
CAR-T cell therapy: current limitations and potential strategies
2021 Standout
COVID-19: consider cytokine storm syndromes and immunosuppression
2020 Standout
Iron-Refractory Iron Deficiency Anemia (IRIDA)
2014
Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
2020
Macrophage Activation Syndrome: different mechanisms leading to a one clinical syndrome
2017
Hemophagocytic lymphohistiocytosis with immunotherapy: brief review and case report
2018
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
2017 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Malignancy‐associated hemophagocytic lymphohistiocytosis in adults: Relation to hemophagocytosis, characteristics, and outcomes
2016
Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis
2019
Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome
2014
Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis
2020
Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine- Directed Therapies
2014
Cytokine Storm
2020 Standout
A Heterozygous RAB27A Mutation Associated with Delayed Cytolytic Granule Polarization and Hemophagocytic Lymphohistiocytosis
2016
Iron-Deficiency Anemia
2015 Standout
Drug Resistance in Cancer: An Overview
2014 Standout
Immunology of Acute and Chronic Wound Healing
2021 Standout
Works of Kai Lehmberg being referenced
Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5)
2012
Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis
2012
Administration of recombinant erythropoietin alone does not improve the phenotype in iron refractory iron deficiency anemia patients
2012
Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte Society
2018
Persistent defective membrane trafficking in epithelial cells of patients with familial hemophagocytic lymphohistiocytosis type 5 due to STXBP2/MUNC18‐2 mutations
2013
Hemophagocytic syndromes — An update
2014
Differentiating Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis from Other Forms of Hemophagocytic Lymphohistiocytosis
2013
Resistance to cytarabine and gemcitabine and in vitro selection of transduced cells after retroviral expression of cytidine deaminase in human hematopoietic progenitor cells
2005
Hemophagocytic lymphohistiocytosis: pathogenesis and treatment
2013
Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis
2012
Subtle differences in CTL cytotoxicity determine susceptibility to hemophagocytic lymphohistiocytosis in mice and humans with Chediak-Higashi syndrome
2011
Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies.
2015
Primary and secondary hemophagocytic lymphohistiocytosis have different patterns of T‐cell activation, differentiation and repertoire
2016
A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes
2012
Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study
2017
Determination of an appropriate cut‐off value for ferritin in the diagnosis of hemophagocytic lymphohistiocytosis
2014
Malignancy‐associated haemophagocytic lymphohistiocytosis in children and adolescents
2015